From the Russell H. Morgan Department of Radiology and Radiological Science, Section of Musculoskeletal Radiology, Johns Hopkins University School of Medicine, 601 N Caroline
St, JHOC 3140A, Baltimore, MD 21287. Received January 29, 2018; accepted March 20. Address correspondence to J.F. (e-mail: jfritz9@jhmi.edu).
Conflicts of interest are listed at the end of this article.
Radiology 2018; 288:25 • https://doi.org/10.1148/radiol.2018180243 • © RSNA, 2018
Musculoskeletal Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
(1) Department of Radiology & Radiological Science, Johns Hopkins University, Baltimore, MD, USA
(2) Siemens Healthcare, Malvern, PA, USA and Erlangen, Germany
Russell H. Morgan Department of Radiology and Radiological Science,
Johns Hopkins Medical Institutions, Baltimore, MD, USA
OBJECTIVE. MR neurography (MRN) has increasingly been used in clinical practice for the evaluation of peripheral nerve disease. This article reviews the historic perspective of MRN, the current imaging trends of this modality, and the future directions and applications that have shown potential for improved imaging and diagnostic capabilities.
CONCLUSION. MRN has come a long way in the past 2 decades. Excellent depiction of 3D nerve anatomy and pathology is currently possible. Further technical developments in diffusion-based nerve and muscle imaging, whole-body MRN, and nerve-specific MR contrast agents will likely play a major role in advancing this novel field and understanding peripheral neuromuscular diseases in the years to come.
(1) University of Texas Southwestern Medical Center, Dallas, TX, USA
(2) The Russel H. Morgan Department of Radiology and Radiological Science,
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Theodoros Soldatos, MD, PhD • Gustav Andreisek, MD • Gaurav K. Thawait, MD • Roman Guggenberger, MD • Eric H. Williams, MD • John A. Carrino, MD, MPH • Avneesh Chhabra, MD
(1) Johns Hopkins University, Baltimore, MD, USA
(2) Siemens Healthcare, MR RD Management, Malvern, PA, USA
Musculoskeletal Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
OBJECTIVE. MR neurography (MRN) has increasingly been used in clinical practice for the evaluation of peripheral nerve disease. This article reviews the historic perspective of MRN, the current imaging trends of this modality, and the future directions and applications that have shown potential for improved imaging and diagnostic capabilities.
CONCLUSION. MRN has come a long way in the past 2 decades. Excellent depiction of 3D nerve anatomy and pathology is currently possible. Further technical developments in diffusion-based nerve and muscle imaging, whole-body MRN, and nerve-specific MR contrast agents will likely play a major role in advancing this novel field and understanding peripheral neuromuscular diseases in the years to come.
(1) University of Texas Southwestern Medical Center, Dallas, TX, USA
(2) The Russel H. Morgan Department of Radiology and Radiological Science,
Johns Hopkins University School of Medicine, Baltimore, MD, USA
(1) Department of Radiology & Radiological Science, Johns Hopkins University, Baltimore, MD, USA
(2) Siemens Healthcare, Malvern, PA, USA and Erlangen, Germany
Russell H. Morgan Department of Radiology and Radiological Science,
Johns Hopkins Medical Institutions, Baltimore, MD, USA
Theodoros Soldatos, MD, PhD • Gustav Andreisek, MD • Gaurav K. Thawait, MD • Roman Guggenberger, MD • Eric H. Williams, MD • John A. Carrino, MD, MPH • Avneesh Chhabra, MD
(1) Johns Hopkins University, Baltimore, MD, USA
(2) Siemens Healthcare, MR RD Management, Malvern, PA, USA
From the Russell H. Morgan Department of Radiology and Radiological Science, Section of Musculoskeletal Radiology, Johns Hopkins University School of Medicine, 601 N Caroline
St, JHOC 3140A, Baltimore, MD 21287. Received January 29, 2018; accepted March 20. Address correspondence to J.F. (e-mail: jfritz9@jhmi.edu).
Conflicts of interest are listed at the end of this article.
Radiology 2018; 288:25 • https://doi.org/10.1148/radiol.2018180243 • © RSNA, 2018
